"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."

During the past decade, Aspirus Heart and Vascular Institute - Research and Education conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aspirus Heart and Vascular Institute - Research and Education" are "Coronary Artery Disease" (2 trials), "Atherosclerosis of Native Arteries of the Extremities" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Aspirus Heart and Vascular Institute - Research and Education" in a lesser frequency.

Most popular intervention types in "Aspirus Heart and Vascular Institute - Research and Education" are "Device" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "3 months of dual antiplatelet therapy (DAPT)" (1 trials), "Aspirin" (1 trials), "ELUVIA (Stent Implantation)" (1 trials), "PROMUS Coronary Stent System" (1 trials) and "PROMUS Element Coronary Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Heart and Vascular Institute - Research and Education" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Aspirus Heart and Vascular Institute - Research and Education". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aspirus Heart and Vascular Institute - Research and Education, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Heart and Vascular Institute - Research and Education, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".